R. Michels

Economic Evaluation of a Tumour-Agnostic Therapy: Dutch Economic Value of Larotrectinib in TRK Fusion-Positive Cancers

C. V. van Herpen, E. Kapiteijn, M. Krol, 2022, Applied Health Economics and Health Policy.

Health state utilities for infertility and subfertility

A. Nap, L. Goossens, M. Krol, 2019, Reproductive Health.

Cost Effectiveness of Cladribine Tablets for the Treatment of Relapsing-Remitting Multiple Sclerosis in The Netherlands

G. Harty, G. Hengstman, K. Schiffers, 2019, Applied Health Economics and Health Policy.

Concerns, quality of life, access to care and productivity of the general population during the first 8 weeks of the coronavirus lockdown in Belgium and the Netherlands

L. Goossens, M. Krol, H. van Ballegooijen, 2021, BMC Health Services Research.

Concerns, quality of life, access to care and productivity of the general population during the first 8 weeks of the coronavirus lockdown in Belgium and the Netherlands

L. Goossens, M. Krol, H. van Ballegooijen, 2020, medRxiv.

A Delphi panel on treatment of high disease activity relapsing remitting multiple sclerosis in the Netherlands.

E. Zeinstra, P. Bouma, M. Krol, 2020, Journal of comparative effectiveness research.